These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 36081907)

  • 1. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
    Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
    Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
    Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
    Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
    BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel Prognostic Markers Associated With Laryngeal Squamous Cell Carcinoma Using Comprehensive Analysis.
    Huang C; He J; Dong Y; Huang L; Chen Y; Peng A; Huang H
    Front Oncol; 2021; 11():779153. PubMed ID: 35087752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
    Yang F; Zhou LQ; Yang HW; Wang YJ
    Front Genet; 2022; 13():927614. PubMed ID: 36092911
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
    Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
    Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
    Zhong Q; Zhou L; Zhu D
    J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
    Xu C; Xu H; Liu B
    PeerJ; 2023; 11():e16364. PubMed ID: 38025757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
    Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.
    Shen Y; Li L; Lu Y; Zhang M; Huang X; Tang X
    Front Genet; 2021; 12():685104. PubMed ID: 34322156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.